Concepts (59)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Flunarizine | 1 | 2018 | 2 | 0.160 |
Why?
|
| Cancer-Associated Fibroblasts | 1 | 2019 | 116 | 0.140 |
Why?
|
| Neoplastic Stem Cells | 2 | 2016 | 1456 | 0.140 |
Why?
|
| ras Proteins | 1 | 2018 | 804 | 0.120 |
Why?
|
| Transforming Growth Factor beta | 1 | 2019 | 1109 | 0.110 |
Why?
|
| Drug Repositioning | 1 | 2013 | 52 | 0.110 |
Why?
|
| Blood Vessels | 1 | 2014 | 232 | 0.110 |
Why?
|
| Autophagy | 1 | 2018 | 911 | 0.100 |
Why?
|
| Stromal Cells | 1 | 2016 | 825 | 0.100 |
Why?
|
| Ovarian Neoplasms | 2 | 2019 | 4795 | 0.100 |
Why?
|
| Wnt Signaling Pathway | 1 | 2014 | 444 | 0.090 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2014 | 550 | 0.090 |
Why?
|
| Tumor Microenvironment | 2 | 2019 | 3035 | 0.090 |
Why?
|
| Models, Biological | 1 | 2013 | 3194 | 0.060 |
Why?
|
| Genes, Reporter | 2 | 2018 | 820 | 0.060 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2014 | 1386 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2019 | 9042 | 0.050 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2014 | 3658 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2019 | 3917 | 0.040 |
Why?
|
| Biomarkers, Tumor | 1 | 2019 | 10708 | 0.040 |
Why?
|
| Autophagosomes | 1 | 2018 | 40 | 0.040 |
Why?
|
| Signal Transduction | 4 | 2019 | 12103 | 0.040 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2018 | 561 | 0.030 |
Why?
|
| Proteolysis | 1 | 2018 | 380 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2019 | 14617 | 0.030 |
Why?
|
| Adenocarcinoma | 1 | 2014 | 7914 | 0.030 |
Why?
|
| Paracrine Communication | 1 | 2016 | 128 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2019 | 680 | 0.030 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2019 | 499 | 0.030 |
Why?
|
| Cell Tracking | 1 | 2014 | 38 | 0.030 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2014 | 61 | 0.030 |
Why?
|
| Lentivirus | 1 | 2014 | 164 | 0.030 |
Why?
|
| Cell Hypoxia | 1 | 2014 | 353 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 2014 | 494 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2013 | 396 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2014 | 693 | 0.020 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2014 | 396 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2014 | 659 | 0.020 |
Why?
|
| Heterografts | 1 | 2014 | 738 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2019 | 5759 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2014 | 1553 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2013 | 16215 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2014 | 1857 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2019 | 7238 | 0.020 |
Why?
|
| Survival Rate | 1 | 2019 | 12541 | 0.020 |
Why?
|
| Mice | 2 | 2018 | 35600 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2016 | 3844 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 7381 | 0.020 |
Why?
|
| Female | 4 | 2019 | 148940 | 0.010 |
Why?
|
| Disease Progression | 1 | 2016 | 6867 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2013 | 6256 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2018 | 14849 | 0.010 |
Why?
|
| Humans | 5 | 2019 | 270740 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2013 | 5315 | 0.010 |
Why?
|
| Animals | 2 | 2018 | 61956 | 0.010 |
Why?
|
| Prognosis | 1 | 2019 | 22505 | 0.010 |
Why?
|
| Bone Neoplasms | 1 | 2013 | 2665 | 0.010 |
Why?
|
| Brain Neoplasms | 1 | 2013 | 4958 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2013 | 12033 | 0.010 |
Why?
|